Andrew James King - 07 Jun 2021 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role
Chief Scientific Officer
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 Jun 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 18:14:17 UTC
Next filing
08 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Employee Stock Option (Right to Buy) Award $0 +21,500 $0.000000 21,500 07 Jun 2021 Common Stock 21,500 $17.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on June 7, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.